BASTA JAMES
EVP, General Counsel
BASTA JAMES has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 3, 2026.
On the most recent filing, BASTA JAMES is listed as EVP, General Counsel at Intellia Therapeutics, Inc. Inside the rolling window, BASTA JAMES reported no open-market purchases and 2 open-market sales totaling $112K in NTLA. The largest disclosed transaction in the window is a sale of 10,397 NTLA shares on Jan 5, 2026, worth $96K.
Companies traded
Other insiders at NTLA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$112K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BASTA JAMES made?
BASTA JAMES has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does BASTA JAMES trade?
BASTA JAMES has filed SEC Form 4 disclosures for 1 company, including NTLA.
When was BASTA JAMES's most recent SEC Form 4 filing?
BASTA JAMES's most recent SEC Form 4 filing on Tracefour is dated Mar 3, 2026.
What is BASTA JAMES's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BASTA JAMES is listed as EVP, General Counsel.
What is BASTA JAMES's total buy and sell value in the current window?
Inside the rolling retention window, BASTA JAMES bought $0 and sold $112K based on SEC Form 4 filings.
What was BASTA JAMES's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,397 NTLA shares on 2026-01-05, worth $96K, per SEC Form 4 filings.